biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > You know you're a bagholder when....

<< Previous

Bullboard Posts

Next >>

Post by Aarcoron Jan 28, 2022 11:26am

261 Views

Post# 34371426

You know you're a bagholder when....

the grandmaster shill tells everyone he no longer owns any bioasis shares. And since his bad divorce from Rathjen we start to see negative posts for the first time in years. What absolute clown theatre.

With that aside, due to the current business plan now admitted to be an absolute failure, the focus is now on "strategic alternatives".

This could be a case study for business undergrads to analyze how incompetent (or worse) management can destroy a biotech company before it even has a chance to show if it's lone drug works or doesn't.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property